Abstract | AIM: To investigate the mechanism of peplomycin (PEP)-induced apoptosis in liver carcinoma cell line (Bel-7402). METHODS: Growth inhibition by PEP was analyzed using 3- 4,5-Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic cells were detected using Hoechest 33258 staining, and confirmed by flow cytometric analysis and DNA fragmentation analysis. The expression of cyclin A and B1 were determined by flow cytometry and Western blot. Annexin V assay was measured by flow cytometric analysis. RESULTS: PEP induced apoptosis and then inhibited cell proliferation in liver carcinoma cell line Bel-7402. Cells treated with PEP 50 mumol/L for 15 h were arrested in G2-phase with dramatical expression of cyclin A and a little change in cyclin B1. Almost all the apoptosis occurred in cells undergoing the G1-phase after treatment for 24 h. CONCLUSION:
Peplomycin induced G1-phase specific apoptosis in Bel-7402 involving G2-phase arrest.
|
Authors | Hong-ying Chen, Cong-yi Zheng, Guo-lin Zou, Da-xing Xie, Jian-ping Gong |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 25
Issue 12
Pg. 1698-704
(Dec 2004)
ISSN: 1671-4083 [Print] United States |
PMID | 15569418
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Cyclin A
- Cyclin B
- Peplomycin
|
Topics |
- Antibiotics, Antineoplastic
(pharmacology)
- Apoptosis
(drug effects)
- Carcinoma, Hepatocellular
(metabolism, pathology)
- Cell Line, Tumor
- Cyclin A
(metabolism)
- Cyclin B
(metabolism)
- G1 Phase
- G2 Phase
- Humans
- Liver Neoplasms
(metabolism, pathology)
- Peplomycin
(pharmacology)
|